July 6, 2017 | The Israeli cancer diagnostic company MobileODT recently completed a $6.85 million funding round led by the OrbiMed Advisors LLC venture capital fund. This brings their total funding up to $13 million since their inception in 2012. Founded by Ariel Beery and David Levitz, MobileODT uses mobile phones to detect cancer; their first product is an FDA cleared internet-connected mobile colposcope that detects cervical cancer. The product has already screened more than 16 000 women in over 25 countries.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments